Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +47.56%
#3 Cysic Cysic +41.67%
#4 Glidr Glidr +36.41%
#5 Walrus Walrus +29.37%
#6 Humanity Humanity +23.38%
#7 Codatta Codatta +16.38%
#8 Enso Enso +16.32%
#9 Tutorial Tutorial +15.81%
#10 Ribbita by Virtuals Ribbita by Virtuals +14.43%
Coin of the day
EXOD EXOD
Настройки
Язык
Pусский
Валюта
USD
Тема
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Ранг среди акций #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Цена акции
$0.069
Последняя синхронизация: 2024-07-22
Рыночная капитализация
$2.06M
Изменение (1 день)
-1.43%
Изменение (1 год)
0.00%
Страна
US
Торговля DermTech, Inc. (DMTK)

Категория

Healthcare
Выручка компании DermTech, Inc. (DMTK)
Выручка на Mar 2024 TTM: $15.66M
Согласно последним финансовым отчетам DermTech, Inc., текущая выручка компании (TTM) составляет $15.66M. В 2022 году компания получила выручку $14.52M больше, чем выручке в 2021 году, которая составила $11.84M. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки DermTech, Inc. с 2012 по 2026
Выручка на конец каждого года
Год Выручка Изменить
2026 (TTM) $15.66M 2.41%
2023 $15.30M 5.36%
2022 $14.52M 22.64%
2021 $11.84M 101.16%
2020 $5.89M 74.94%
2019 $3.36M 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
Выручка аналогичных компаний или конкурентов
Компания Выручка Разница в выручке Страна
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $46.34B 295,712.05%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $25.11B 160,184.73%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $2.71B 17,182.16%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $4.55B 28,968.07%
US